Tailored tools to improve pharmacotherapy in infants.

about

Neonatal drug therapy: The first frontier of therapeutics for children Neonatal medicines research: challenges and opportunities.The prevalence of child-specific utilities in NICE appraisals for paediatric indications: rise of the economic orphans?Antimicrobial dosing in neonates.

P2860

Q27013749-558FE606-31BC-4008-8FAD-ED05D706FF06 Q38469763-476ED66D-24B2-4BAB-B99F-8FF6760511E5 Q38809090-B7981C33-5936-4D6C-B5EA-D7B50AB3FFCE Q40380011-70B570BE-5CBC-4574-A826-E1EC2B3F6C0E

P2860

Tailored tools to improve pharmacotherapy in infants.

Item

http://www.wikidata.org/entity/Q38222870

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Tailored tools to improve pharmacotherapy in infants.

@en

type

Item

label

Tailored tools to improve pharmacotherapy in infants.

@en

prefLabel

Tailored tools to improve pharmacotherapy in infants.

@en

P1476

Tailored tools to improve pharmacotherapy in infants.

@en

P2093

Karel Allegaert

http://www.w3.org/2001/XMLSchema#string

P2860

Innovative clinical trial design for pediatric therapeutics

Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data

Educational paper: do we need neonatal clinical pharmacologists?

Strategic biomarkers for drug development in treating rare diseases and diseases in neonates and infants

Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother

The gasping syndrome and benzyl alcohol poisoning

Administration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917 on amidarone absorption in rats

Changes in individual drug-independent system parameters during virtual paediatric pharmacokinetic trials: introducing time-varying physiology into a paediatric PBPK model

Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation.

Medication errors and adverse drug events in pediatric inpatients.

P304

1069-1078

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425255.2014.931937

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karel Allegaert

P577

2014-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24961300

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

Tailored tools to improve pharmacotherapy in infants.

about

P2860

P2860

Tailored tools to improve pharmacotherapy in infants.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921